منابع مشابه
Thrombotic microangiopathy in membranous lupus nephritis
Introduction Systemic lupus erythematous (SLE) is a systemic autoimmune disease having various clinical and pathological manifestations. The vascular manifestations of SLE range from most common uncomplicated vascular immune deposits to rare renal vasculitis. The non-immune, non-inflammatory thrombotic microangiopathy (TMA) is a rare vascular manifestation of SLE, which is therapeutically chall...
متن کاملKikuchi disease preceding systemic lupus erythematosus with membranous lupus nephritis
Kikuchi disease (KD) is a rare form of necrotizing lymphadenitis. KD usually presents with cervical lymphadenopathy and fever in young women. It tends to run a benign course and resolve spontaneously within months. The aetiology of the disease is still unclear although a variety of infectious agents have been postulated. There is also a documented but rare association with systemic lupus erythe...
متن کاملTreatment of lupus nephritis.
Renal involvement in systemic lupus erythematosus patients is a severe disease manifestation characterized by various clinical and histopathological alterations. The revised International Society of Nephrology/Renal Pathology Society 2003 classification defines the subclasses of lupus nephritis (LN) according to their pathological glomerular patterns, which has a crucial impact on the prognosis...
متن کاملRituximab alone as induction therapy for membranous lupus nephritis
The optimal treatment for pure membranous lupus nephritis (MLN) remains undetermined. Rituximab constitutes a promising therapeutic option for lupus nephritis and is currently being evaluated for use in idiopathic membranous nephritis. We retrospectively analysed the efficacy and tolerance of rituximab as a monotherapy in the induction treatment of pure MLN.We retrospectively investigated SLE p...
متن کاملTreatment of proliferative and membranous lupus nephritis: review of key clinical trials.
Lupus nephritis (LN) is a common complication of systemic lupus erythematosus (SLE), which is associated with significant morbidity and mortality. Renal involvement in SLE is heterogeneous; therefore, the treatment of LN is determined by the pathological type of LN and ranges from nonspecific measures such as maintenance of adequate blood pressure control and blockade of renin-angiotensin-aldos...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Clinical Immunology
سال: 2000
ISSN: 0911-4300,1349-7413
DOI: 10.2177/jsci.23.652